Company: ACTG
Filing Date: 2025-05-09
Form Type: 10-Q
Source: 0000934549-25-000021
Chunk: 23

Company: ACACIA RESEARCH CORP
Filing Date: 2025-05-09
Form: 10-Q
Item: Part I, Item 1
Chunk 23
---
 in subsidiaries$23,528 $(189)Adjustments to reconcile net income (loss) including noncontrolling interests in subsidiaries to net cash provided by (used in)   operating activities:Depreciation, depletion and amortization10,610 4,568 Accretion of asset retirement obligation434 — Compensation expense for share-based awards922 858 (Gain) loss on foreign currency exchange(155)18 Change in fair value of equity securities4,777 26,701 Gain on sale of equity securities(1,605)(28,861)Unrealized loss on derivatives4,978 629 Deferred income taxes, net of acquired net deferred tax assets3,323 (3,652)Changes in assets and liabilities:Accounts receivable(68,814)65,156 Inventories1,220 1,041 Prepaid expenses and other assets728 (10,752)Accounts payable and accrued expenses1,223 7,108 Royalties and contingent legal fees payable21,249 (7,811)Deferred revenue7 25 Net cash provided by operating activities2,425 54,839 Cash flows from investing activities:Purchases of equity securities(4,827)(15,544)Sales of equity securities6,726 57,854 Acquisition, net of cash acquired and working capital adjustments (Note 3)1,230 — Purchases of property and equipment and additions to oil and gas properties(2,090)(270)Net cash provided by investing activities1,039 42,040 Cash flows from financing activities:Borrowings on the Revolving credit facility— 2,500 Paydown of Revolving Credit Facility(5,000)— Paydown of Term Loan(600)— Taxes paid related to net share settlement of share-based awards(471)(674)Net cash (used in) provided by financing activities(6,071)1,826 Effect of exchange rates on cash and cash equivalents691 (34)(Decrease) increase in cash and cash equivalents(1,916)98,671 Cash and cash equivalents, beginning273,880 340,091 Cash and cash equivalents, ending$271,964 $438,762 Supplemental schedule of cash flow information:Noncash investing and financing activities:Patent acquisition of prepaid option 15,000 — Accrued patent costs— (4,000